feed
view company updates
tools
perform investment research
network
join events & discussions
advisory
about us
Redeye Capital
Xspray Pharma: Progress in Q1
Research Note
2018-05-14
09:03
Xspray are showing progress with production and setup, and study results with lead candidate HyNap-Dasa should be presented in Q3.
MS
Mathias Spinnars
Sign up for free to continue
Sign up with Email
Sign in with Google
Already a member?
Sign in
Disclosures and disclaimers
Premium Plan required to unlock
Unlock companies to access
more high quality research.
View Plans